Abstract
The activation of the bone morphogenic protein (BMP) signaling pathway in cancer cells has been shown to enhance migration and tumor angiogenesis and promote survival. The BMP signaling pathway regulates benign cells in the tumor microenvironment and is a known regulator of immune cells. The development of BMP receptor inhibitors has allowed the study of tumor xenografts in mice. We describe a double-humanized mouse model with adoptively transferred human immune and human tumor cells that can be used to assess the effects of BMP inhibitors on these human cells in vivo.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Augeri DJ, Langenfeld E, Castle M, Gilleran JA, Langenfeld J (2016) Inhibition of BMP and of TGFβ receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death. Mol Cancer 15(1):27
Langenfeld E, Deen M, Zachariah E, Langenfeld J (2013) Small molecule antagonist of the bone morphogenetic protein type I receptors suppresses growth and expression of Id1 and Id3 in lung cancer cells expressing Oct4 or nestin. Mol Cancer 12(1):129
Langenfeld E, Hong CC, Lanke G, Langenfeld J (2013) Bone morphogenetic protein type I receptor antagonists decrease growth and induce cell death of lung cancer cell lines. PLoS One 8(4):e61256
Langenfeld EM, Kong Y, Langenfeld J (2006) Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1/5. Oncogene 25(5):685–692
Langenfeld EM, Langenfeld J (2004) Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors11NIH K22 grant CA91919-01A1 and UMDNJ foundation to J. Langenfeld. Mol Cancer Res 2(3):141–149
Langenfeld EM, Calvano SE, Abou-Nukta F, Lowry SF, Amenta P, Langenfeld J (2003) The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells. Carcinogenesis 24(9):1445–1454
Hao J, Ho JN, Lewis JA, Karim KA, Daniels RN, Gentry PR et al (2010) In vivo structure− activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors. ACS Chem Biol 5(2):245–253
Langenfeld EM, Bojnowski J, Perone J, Langenfeld J (2005) Expression of bone morphogenetic proteins in human lung carcinomas. Ann Thorac Surg 80(3):1028–1032
Counting cells using a hemocytometer. Abcam. http://www.abcam.com/protocols/counting-cells-using-a-haemocytometer. Accessed 19 Jan 2017
Patton J, Vuyyuru R, Siglin A, Root M, Manser T (2015) Evaluation of the efficiency of human immune system reconstitution in NSG mice and NSG mice containing a human HLA.A2 transgene using hematopoietic stem cells purified from different sources. J Immunol Methods 422:13–21
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Newman, J., NeMoyer, R., Zloza, A., Langenfeld, J. (2019). Double-Humanized Mouse Model to Study Bone Morphogenetic Protein (BMP) Signaling in Tumor Xenografts. In: Rogers, M. (eds) Bone Morphogenetic Proteins. Methods in Molecular Biology, vol 1891. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8904-1_19
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8904-1_19
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8903-4
Online ISBN: 978-1-4939-8904-1
eBook Packages: Springer Protocols